Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.65 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | DUT | P33316 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2493446 | 0.89 | KIF11 (0.59) | KIF11KCNN4POLBDUTLMNA | |
| SCHEMBL20710206 | 0.88 | KIF11 (0.53) | KIF11KCNN4POLBKDM4ELMNA | |
| SCHEMBL12264131 | 0.87 | KIF11 (0.74) | KIF11KCNN4DUTALDH1A1TDP1 | |
| SCHEMBL3684180 | 0.87 | KIF11 (0.57) | KIF11KCNN4POLBDUTKDM4E | |
| SCHEMBL913501 | 0.86 | KIF11 (0.55) | KIF11KCNN4POLBDUTKDM4E | |
| SCHEMBL14286703 | 0.86 | KIF11 (0.55) | KIF11KCNN4POLBDUTKDM4E | |
| SCHEMBL284800 | 0.84 | KIF11 (0.47) | KIF11KCNN4POLBKDM4ELMNA | |
| SCHEMBL4363002 | 0.84 | KIF11 (0.49) | KIF11KCNN4POLBKDM4ELMNA | |
| SCHEMBL12225852 | 0.84 | KIF11 (0.49) | KIF11KCNN4POLBKDM4ELMNA | |
| SCHEMBL12264133 | 0.83 | KIF11 (0.68) | KIF11KCNN4DUTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150328107-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2015-11-19 | — | — | US | claimed |
| CN-102264357-B | Melanin production inhibitor | POLA CHEM IND INC | 2015-04-01 | — | — | CN | claimed |
| EP-2845587-A2 | Melanin production inhibitor | Pola Chemical Industries Inc. (JP) | 2015-03-11 | — | — | EP | claimed |
| US-20140363389-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2014-12-11 | — | — | US | claimed |
| CN-102264357-A | Melanin production inhibitor | — | 2011-11-30 | — | — | CN | claimed |
| EP-2380567-A1 | MELANIN PRODUCTION INHIBITOR | Pola Chemical Industries Inc. (JP) | 2011-10-26 | — | — | EP | claimed |
| US-20110243865-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2011-10-06 | — | — | US | claimed |
| JP-63054384-A | — | — | None | — | — | JP | disclosed |
| EP-4234042-B1 | MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR | POLA CHEM IND INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250215028-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | UNIVERSITE DE ROUEN-NORMANDIE (FR) | 2025-07-03 | — | — | US | disclosed |
| US-20240173303-A1 | 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase | INCYTE HOLDINGS CORPORATION | 2024-05-30 | — | — | US | disclosed |
| EP-2911669-B1 | SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER | UNIV CHICAGO (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4234042-A1 | MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR | Pola Chemical Industries, Inc. (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-5106957-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER DIAGNOSTICS INC. (US) | 1992-04-21 | — | — | US | disclosed |
| US-5055578-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER DIAGNOSTICS INC. (US) | 1991-10-08 | — | — | US | disclosed |
| US-5032677-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER INTERNATIONAL INC. (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0383281-A1 | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1990-08-22 | — | — | EP | disclosed |
| EP-0341298-A1 | FLUORESCENT POLY(ARYLPYRIDINE) RARE EARTH CHELATES | Baxter Diagnostics Inc. (US) | 1989-11-15 | — | — | EP | disclosed |
| JP-S6354384-A | MIXED ACID-TYPE POLYMERIZABLE PHOSPHOLIPID DERIVATIVE AND PRODUCTION THEREOF | TOSOH CORP | 1988-03-08 | — | — | JP | disclosed |
| US-3985875-A | RENIN INHIBITION, ANTIHYPERTENSIVE, ANTICHOLESTEROL AGENTS | DAINIPPON PHARMACEUTICAL CO., LTD. (JA) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215028-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | PHOSPHO1, SGMS1, SGPL1 | KIF11 2164/4885KCNN4 3964/4885POLB 1525/4885 |
| US-20240173303-A1 | 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase | IDO1, IDO2, INMT | KIF11 3126/4885KCNN4 3455/4885POLB 2730/4885 |
| US-20110243865-A1 | MELANIN PRODUCTION INHIBITOR | TYR, F12, TH | KIF11 4556/4885KCNN4 2642/4885POLB 3212/4885 |
| US-20150328107-A1 | MELANIN PRODUCTION INHIBITOR | TYR, MC1R, F12 | KIF11 4605/4885KCNN4 2867/4885POLB 3196/4885 |
| US-20140363389-A1 | MELANIN PRODUCTION INHIBITOR | TYR, F12, MC1R | KIF11 4611/4885KCNN4 2809/4885POLB 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.